Alexander McGirr1, Gabriel Diaconu, Marcelo T Berlim, Gustavo Turecki. 1. McGill Group for Suicide Studies, Douglas Mental Health University Institute, McGill University, Montreal, Canada; University of Toronto, Faculty of Medicine, Toronto, Canada.
Abstract
BACKGROUND: Suicidal behaviour aggregates in families and HPA-axis dysregulation may help explain part of this familial aggregation. Nevertheless, exogenous manipulation of the HPA-axis has yielded mixed results. Naturalistic and non-pharmacological inductions of the HPA-axis do not suggest hyper-responsiveness, yet suggest greater cognitive consequences of stress in individuals at risk for suicide. In this study, we aimed to characterize the relationship between plasma cortisol and an increased risk for suicide, as defined by family history. METHOD: Patients (N=148) with depressive disorders underwent psychopathological assessment, including structured investigation of past suicidal behaviour and underwent laboratory blood testing of cortisol. They also completed a family history interview investigating family psychopathology and suicidal behaviour, representing data on 848 first degree relatives. The relationship between plasma cortisol, past suicidal behaviour and suicidal behaviour among first degree relatives was examined. RESULTS: Lower levels of plasma cortisol were associated with a personal and family history of suicidal behaviour, as well as a family history of depression among first degree relatives. Multivariate analyses controlling for significant psychopathology replicated the association between lower levels of plasma cortisol, a family history of suicidal behaviour and personal history of suicide attempts, but not a family history of depression. Controlling for personal history of suicide attempts revealed an independent association between plasma cortisol and family history of suicidal behaviour, with an additional contribution by family history of depression in predicting the latter. CONCLUSIONS: Lower plasma cortisol is associated with a family history of suicide among depressed outpatients, independent of psychopathology and previous suicide attempts.
BACKGROUND: Suicidal behaviour aggregates in families and HPA-axis dysregulation may help explain part of this familial aggregation. Nevertheless, exogenous manipulation of the HPA-axis has yielded mixed results. Naturalistic and non-pharmacological inductions of the HPA-axis do not suggest hyper-responsiveness, yet suggest greater cognitive consequences of stress in individuals at risk for suicide. In this study, we aimed to characterize the relationship between plasma cortisol and an increased risk for suicide, as defined by family history. METHOD:Patients (N=148) with depressive disorders underwent psychopathological assessment, including structured investigation of past suicidal behaviour and underwent laboratory blood testing of cortisol. They also completed a family history interview investigating family psychopathology and suicidal behaviour, representing data on 848 first degree relatives. The relationship between plasma cortisol, past suicidal behaviour and suicidal behaviour among first degree relatives was examined. RESULTS: Lower levels of plasma cortisol were associated with a personal and family history of suicidal behaviour, as well as a family history of depression among first degree relatives. Multivariate analyses controlling for significant psychopathology replicated the association between lower levels of plasma cortisol, a family history of suicidal behaviour and personal history of suicide attempts, but not a family history of depression. Controlling for personal history of suicide attempts revealed an independent association between plasma cortisol and family history of suicidal behaviour, with an additional contribution by family history of depression in predicting the latter. CONCLUSIONS: Lower plasma cortisol is associated with a family history of suicide among depressed outpatients, independent of psychopathology and previous suicide attempts.
Authors: Nadine M Melhem; John G Keilp; Giovanna Porta; Maria A Oquendo; Ainsley Burke; Barbara Stanley; Thomas B Cooper; J John Mann; David A Brent Journal: Neuropsychopharmacology Date: 2015-10-09 Impact factor: 7.853
Authors: Mina M Rizk; Hanga Galfalvy; Tanya Singh; John G Keilp; M Elizabeth Sublette; Maria A Oquendo; J John Mann; Barbara Stanley Journal: J Affect Disord Date: 2018-04-01 Impact factor: 4.839
Authors: Nadine M Melhem; Sara Munroe; Anna Marsland; Katarina Gray; David Brent; Giovanna Porta; Antoine Douaihy; Mark L Laudenslager; Frank DePietro; Rasim Diler; Henry Driscoll; Priya Gopalan Journal: Psychoneuroendocrinology Date: 2017-01-10 Impact factor: 4.905
Authors: M Elizabeth Sublette; Hanga C Galfalvy; Dietmar Fuchs; Manana Lapidus; Michael F Grunebaum; Maria A Oquendo; J John Mann; Teodor T Postolache Journal: Brain Behav Immun Date: 2011-05-14 Impact factor: 7.217
Authors: Barbara Stanley; Christina A Michel; Hanga C Galfalvy; John G Keilp; Mina M Rizk; Randall Richardson-Vejlgaard; Maria A Oquendo; J John Mann Journal: Psychiatry Res Date: 2019-07-16 Impact factor: 3.222
Authors: A Giurgiuca; B Nemes; S Schipor; A Caragheorgheopol; V Boscaiu; D Cozman; C Tudose Journal: Acta Endocrinol (Buchar) Date: 2017 Apr-Jun Impact factor: 0.877
Authors: Liat Itzhaky; Hanga Galfalvy; John G Keilp; Ilana Gratch; Beth S Brodsky; Barbara H Stanley Journal: Psychiatry Date: 2020-02-18 Impact factor: 2.458